GENERAL COMMENTS
This is a very well-written manuscript presenging data from a nationally representative sample that extends prior findings on the strong association between bipolar disorder and cardiovascular mortality. The statistical methods are rigorous and appropriate. The data is well-presented and including reporting of excess deaths, which is useful for assessing public health impact.
1) Introduction, the sentence referring to "different CVD subgroups" is not clear. I think the authors are referencing different types of vascular mortality.
2) Please use the phrase "bipolar" to describe the disorder and not people. Please replace the phrase "bipolar patients" with the less problematic although more lengthy "patients with bipolar disorder." For clarification, the authors are encouraged to see Flanagan and Davidson ""Schizophrenics," "Borderlines," and the Lingering Legacy of Misplaced Concreteness: An Examination of the Persistent Misconception That the DSM Classifies People Instead of Disorders." 3) Discussion, Strengths and Limitations, paragraph 1. Please drop phrase beginning "which would have been of interest since antidepressant use have been linked to incrased risk of fatal coronary heart disease" and reference 10. This short phrase misinterprets a very complex literature and the study cited uses antidepressant exposure as a marker for depression itself. 4) Do the authors have any data from Sweden or countries with similar health care systems related to the proportion of individuals with bipolar disorder are at some point hospitalized? If so, that might add to the discussion of strengths limitations.
Discretionary Revisions (encourage the authors to consider at their discretion): 1) Although the point is clear, the use of the phrase "somatic illness" for cause of death invokes some unnecessary dualism. Given use of unnatural for suicides an accidents, I encourage the authors to consider use of other natural causes.
2) Discussion, CVD undertreated in bipolar disorder, the possibility that those with bipolar disorder have greater burden of sudden cardiac death could be considered as another explanation for the only slightly increased hospital admission rates.
3) I think the authors should briefly include mention of the universal free access to medical care in Sweden as a strength of the study as well (this is mentioned in discussion trying to explain only slightly increased hospital admissions. 
This study examined causes of death among adults with bipolar disorder, and replicated previous findings regarding increased risk of CVD death and unchanged rates of CVD treatment nonetheless. The sample is unique, the findings are strong, the paper is well written, and topic is exceedingly timely and of tremendous public health importance. Limitations are appropriately acknowledged. The manuscript would benefit from covering the previous literature in greater detail and going into greater depth regarding putative pathophysiologic links and treatment implications. Suggestion follow below: 1. A stylistic comment: The comparison of medical causes of death vs. suicide is somewhat overemphasized. It would be preferable to demonstrate the burden of CVD rather than highlighting a perceived over-emphasis on suicide. 2. Most of the studies cited re CVD prevalence are Scandinavian; it is worth point out that similar findings have been observed in a representative study of the United States population (Goldstein et al, Bipolar Disorders 2009). The same study also converges with present findings regarding the earlier age of CVD among people with bipolar disorder. Likewise, previous findings from Kilbourne and colleagues regarding younger age of CVD and lower rates of nutritional counseling among adults with bipolar disorder should be acknowledged. Both studies confirm that current findings extend beyond hospitalized samples. 3. The Introduction should more explicitly highlight the specific aspects of this study that extend previous findings. This clarifies the overall rationale for the current study. 4. Previous findings suggested that bipolar disorder confers greater SMR for CVD among females vs. males, whereas the current study did not. Please comment. 5. The number of figures is excessive. 6. Because the study focuses on CVD, it would be helpful to highlight, in the first paragraph of the Discussion and in the abstract, the number of excessive deaths due to CVD. As written, CVD is combined with other somatic illnesses that are not the focus of the current manuscript. 7. In the Discussion, potentially shared biological causes are relatively understated compared to medications and lifestyle. These include inflammation and endothelial dysfunction. 8. The findings regarding undertreatment of CVD should be better contextualized with previous findings on this topic. 9. The Discussion regarding under-treatment could benefit from greater elaboration. For example, a potential explanation suggested by current findings is that under-treatment may be explained by the young age of patients with bipolar disorder who have CVD. Could it be that clinicians are trained and guided to screen for CVD and CVD risk factors at ages that are already too late for patients with bipolar disorder? It would be helpful to summarize the Swedish guidelines for management of medical conditions in bipolar disorder. In particular, is early age of CVD incorporated in those guidelines, in addition to the increased prevalence? This is a very well-written manuscript presenging data from a nationally representative sample that extends prior findings on the strong association between bipolar disorder and cardiovascular mortality. The statistical methods are rigorous and appropriate. The data is well-presented and including reporting of excess deaths, which is useful for assessing public health impact. We thank the reviewer for these comments to our manuscript.
REVIEWER
1) Introduction, the sentence referring to "different CVD subgroups" is not clear. I think the authors are referencing different types of vascular mortality. The text has been changed to "different types of vascular mortality". (p 4) 2) Please use the phrase "bipolar" to describe the disorder and not people. Please replace the phrase "bipolar patients" with the less problematic although more lengthy "patients with bipolar disorder." For clarification, the authors are encouraged to see Flanagan and Davidson ""Schizophrenics," "Borderlines," and the Lingering Legacy of Misplaced Concreteness: An Examination of the Persistent Misconception That the DSM Classifies People Instead of Disorders." We agree with the reviewer and have changed "bipolar patients" to "persons with bipolar disorder". 3) Discussion, Strengths and Limitations, paragraph 1. Please drop phrase beginning "which would have been of interest since antidepressant use have been linked to incrased risk of fatal coronary heart disease" and reference 10. This short phrase misinterprets a very complex literature and the study cited uses antidepressant exposure as a marker for depression itself. The sentence has been deleted. (p 9) 4) Do the authors have any data from Sweden or countries with similar health care systems related to the proportion of individuals with bipolar disorder are at some point hospitalized? If so, that might add to the discussion of strengths limitations. Information about hospitalizations in bipolar disorder has been added, but there is no information about patients only in out-patient treatment. Bipolar I disorder cannot be separated from bipolar II in the register data, but will be much less likely to be hospitalized. (p 9) Discretionary Revisions (encourage the authors to consider at their discretion): 1) Although the point is clear, the use of the phrase "somatic illness" for cause of death invokes some unnecessary dualism. Given use of unnatural for suicides an accidents, I encourage the authors to consider use of other natural causes.
The classification of causes of death varies. We have chosen to keep "somatic illness" and change "unnatural" to "suicides and other external", according to the ICD classification.
2) Discussion, CVD undertreated in bipolar disorder, the possibility that those with bipolar disorder have greater burden of sudden cardiac death could be considered as another explanation for the only slightly increased hospital admission rates. We have added sudden cardiac death, defined as cardiac arrest/ventricular fibrillation, to the causes of death in Table 1 . Although it is increased, the extent does not explain the difference in hospital admissions. (p 10) 3) I think the authors should briefly include mention of the universal free access to medical care in Sweden as a strength of the study as well (this is mentioned in discussion trying to explain only slightly increased hospital admissions. The universal free access to medical care in Sweden has been stressed as a strength of the study. This study examined causes of death among adults with bipolar disorder, and replicated previous findings regarding increased risk of CVD death and unchanged rates of CVD treatment nonetheless. The sample is unique, the findings are strong, the paper is well written, and topic is exceedingly timely and of tremendous public health importance. Limitations are appropriately acknowledged. The manuscript would benefit from covering the previous literature in greater detail and going into greater depth regarding putative pathophysiologic links and treatment implications. We thank the reviewer for these comments, and have extended the coverage of previous literature, putative patophysiologic links, and treatment implications. Although the number of figures is high, we believe that they add specific information that is of interest for the readers. This has been further explained in the Results (p 7). Thus, we have not reduced the number of figures. 6. Because the study focuses on CVD, it would be helpful to highlight, in the first paragraph of the Discussion and in the abstract, the number of excessive deaths due to CVD. As written, CVD is combined with other somatic illnesses that are not the focus of the current manuscript. Excessive deaths due to CVD has been emphasized both in the Discussion (p 8) and in the Abstract. 7. In the Discussion, potentially shared biological causes are relatively understated compared to medications and lifestyle. These include inflammation and endothelial dysfunction. This has been added to the Discussion. (p 10) 8. The findings regarding undertreatment of CVD should be better contextualized with previous findings on this topic. The text on undertreatment of CVD has been revised. (10-11) 9. The Discussion regarding under-treatment could benefit from greater elaboration. For example, a potential explanation suggested by current findings is that under-treatment may be explained by the young age of patients with bipolar disorder who have CVD. Could it be that clinicians are trained and guided to screen for CVD and CVD risk factors at ages that are already too late for patients with bipolar disorder? It would be helpful to summarize the Swedish guidelines for management of medical conditions in bipolar disorder. In particular, is early age of CVD incorporated in those guidelines, in addition to the increased prevalence?
We have added further information to the Discussion regarding under-treatment, including specifying
